標(biāo)題: Titlebook: Management of Localized Pancreatic Cancer; Current Treatment an Susan Tsai,Paul S. Ritch,Douglas B. Evans Book 2019 Springer Nature Switzer [打印本頁(yè)] 作者: False-Negative 時(shí)間: 2025-3-21 18:09
書(shū)目名稱Management of Localized Pancreatic Cancer影響因子(影響力)
書(shū)目名稱Management of Localized Pancreatic Cancer影響因子(影響力)學(xué)科排名
書(shū)目名稱Management of Localized Pancreatic Cancer網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Management of Localized Pancreatic Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Management of Localized Pancreatic Cancer被引頻次
書(shū)目名稱Management of Localized Pancreatic Cancer被引頻次學(xué)科排名
書(shū)目名稱Management of Localized Pancreatic Cancer年度引用
書(shū)目名稱Management of Localized Pancreatic Cancer年度引用學(xué)科排名
書(shū)目名稱Management of Localized Pancreatic Cancer讀者反饋
書(shū)目名稱Management of Localized Pancreatic Cancer讀者反饋學(xué)科排名
作者: 現(xiàn)代 時(shí)間: 2025-3-22 00:11
Susan Tsai,Paul S. Ritch,Douglas B. EvansThe first comprehensive resource which clearly defines the principles of neoadjuvant therapy and provides a clinical framework for successful therapy..Each chapter includes a summary of clinical "pear作者: ACRID 時(shí)間: 2025-3-22 00:39
http://image.papertrans.cn/m/image/622537.jpg作者: 船員 時(shí)間: 2025-3-22 06:37 作者: eardrum 時(shí)間: 2025-3-22 10:33
pection or cognitive support for employees in production, artificial intelligence contributes to creating smart as well as sustainable manufacturing systems. In the area of manufacturing system design, decision support models are increasingly used to facilitate the work of system designers. In this 作者: 主講人 時(shí)間: 2025-3-22 13:08 作者: 兩棲動(dòng)物 時(shí)間: 2025-3-22 17:19 作者: epicardium 時(shí)間: 2025-3-23 00:12 作者: neutralize 時(shí)間: 2025-3-23 04:51
Clinical Staging of Pancreatic Cancer with MDCT and MRI,ximately 7%. This dismal prognosis is in large part related to the advanced stage of disease at the time of diagnosis. To date, complete surgical resection is a major component of a curative treatment paradigm for pancreatic cancer. Patients who undergo incomplete resection have survival rates no di作者: enormous 時(shí)間: 2025-3-23 06:32 作者: dagger 時(shí)間: 2025-3-23 10:21
,Importance of Carbohydrate Antigen 19-9 Monitoring in the?Management of Pancreatic Cancer,tic cancers demonstrate little to no radiographic changes in response to therapy. Lack of reliable radiographic response remains a major challenge to assessing biologic response to therapy and confounds appropriate surgical selection. In addition, subjectivity and inter-reater variability complicate作者: attenuate 時(shí)間: 2025-3-23 14:27 作者: 北京人起源 時(shí)間: 2025-3-23 21:45
Treatment Sequencing for Borderline Resectable Pancreatic Cancer,ignificant tumor-vascular interface, patients are at a high risk of margin-positive resection with a surgery first approach. We advocate for a multimodal approach to the management of these patients in order to mitigate this risk. In this chapter we will discuss the rational for use of preoperative 作者: DIS 時(shí)間: 2025-3-24 01:14
Delivery of Neoadjuvant Versus Adjuvant Therapy in Localized Pancreatic Cancer,States, and almost all are expected to die from the disease [1]. Worldwide, pancreatic cancer is the eighth leading cause of cancer deaths in men (138,100 deaths annually) and the ninth in women (127,900 deaths annually) [2]. It is the third leading cause of cancer-related death in the United States作者: 不可思議 時(shí)間: 2025-3-24 03:05
Neoadjuvant Chemoradiation for Localized Pancreatic Cancer,ion. The role of neoadjuvant or adjuvant therapies in conjunction with surgical resection is well established. The optimal sequencing of these therapies remains controversial. While historically patients with pancreatic cancer were managed with a surgery-first approach, the oncologic rationale for t作者: Obscure 時(shí)間: 2025-3-24 07:09
New Classification of Locally Advanced Pancreatic Cancer, and metastatic disease. These clinical categories provide critical information regarding the resectability status of a tumor based on discreet anatomic criteria gleaned from imaging data. Accurate staging at diagnosis allows clinicians to formulate treatment plans that are consistent and seamless b作者: 樂(lè)章 時(shí)間: 2025-3-24 11:18
Treatment Sequencing for Locally Advanced Pancreatic Cancer,n the strengths of each treatment modality. Four to six months minimum of chemotherapy treats micrometastatic disease and selects out patients who are not appropriate candidates for local therapies. Radiation then sterilizes margins and lymph nodes and treats the perineurium known to commonly be inv作者: 細(xì)查 時(shí)間: 2025-3-24 15:18
Role of Radiation for Locally Advanced Pancreatic Cancer,uestioned. Given the location of the pancreas in the upper abdomen, the use of radiation in this location is technically challenging. Identification of the patients who will benefit from this treatment is pivotal, as is the expertise to execute radiation to defined targets at the required high doses作者: Mangle 時(shí)間: 2025-3-24 22:59 作者: crumble 時(shí)間: 2025-3-25 00:00 作者: 割讓 時(shí)間: 2025-3-25 03:55
Medical Nutrition Therapy Throughout the Continuum of Care for Localized Pancreatic Cancers,onal therapy in pancreatic cancer focuses on adequate intake of calories, protein, and fluids in order to support strength and energy requirements. Nutritional interventions should be targeted at minimizing side effects of adjuvant treatments and helping patients prepare and recover from surgery. Pr作者: Regurgitation 時(shí)間: 2025-3-25 08:45 作者: 酷熱 時(shí)間: 2025-3-25 13:30 作者: 吞吞吐吐 時(shí)間: 2025-3-25 19:34 作者: visual-cortex 時(shí)間: 2025-3-25 21:38 作者: infarct 時(shí)間: 2025-3-26 00:20 作者: mucous-membrane 時(shí)間: 2025-3-26 07:31
The Future of Multidisciplinary Care in Pancreatic Cancer,s engagement and cooperation of multiple specialty services to accurate stage, palliate, and treat patients with operable pancreatic cancer. The purpose of this chapter is to provide an overview of the breadth and depth of specialist required to provide neoadjuvant therapy to patients in the current作者: Infant 時(shí)間: 2025-3-26 10:03 作者: 積云 時(shí)間: 2025-3-26 13:50 作者: 一加就噴出 時(shí)間: 2025-3-26 17:50
Genetic Counseling for Pancreatic Cancer,th reduced penetrance. Each year, additional genes with varying degrees of preliminary evidence are added to the growing list of PC predisposition genes. Thus, it is clear that PC is a genetically diverse disease associated with numerous hereditary syndromes and many yet to be discovered genomic cau作者: Gerontology 時(shí)間: 2025-3-26 20:57
,Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography (FDG-PET) in the?Management of Pancreatields an approximately 18-fold increase in energy production in comparison to glycolysis alone. However, cancer cells are able to compensate by upregulating glucose transporters (GLUT) on the cell membrane, namely, GLUT1, resulting in an increased uptake of glucose into cells.作者: LIMIT 時(shí)間: 2025-3-27 01:30
,The New Bench for the?Academic Surgeon: Precision Medicine,esearchers, the time has come to more intensively immerse within this field. New concepts and methodologies of genomics, epigenomics, pharmacogenomics, and microbiome, high-level bioinformatics and data analytics, along with portable and wearable biosensors and printables, when combined with meticul作者: 暖昧關(guān)系 時(shí)間: 2025-3-27 07:56 作者: 阻止 時(shí)間: 2025-3-27 12:05 作者: Patrimony 時(shí)間: 2025-3-27 13:59 作者: Ordeal 時(shí)間: 2025-3-27 20:54 作者: 都相信我的話 時(shí)間: 2025-3-28 01:39
Book 2019nd to focus on accurate clinical staging and stage-specific treatment sequencing. Sections address important aspects of clinical management of localized pancreatic cancer from diagnosis to surgery. These areas include initial radiographic staging, management of obstructive jaundice, role of chemothe作者: antiandrogen 時(shí)間: 2025-3-28 02:13 作者: reaching 時(shí)間: 2025-3-28 07:50 作者: exceptional 時(shí)間: 2025-3-28 12:37 作者: 是比賽 時(shí)間: 2025-3-28 15:50
l therapy..Each chapter includes a summary of clinical "pearThis book is designed to present a comprehensive understanding for the rationale of neoadjuvant treatment sequencing for localized pancreatic cancer and to focus on accurate clinical staging and stage-specific treatment sequencing. Sections作者: 太空 時(shí)間: 2025-3-28 22:29
Delivery of Neoadjuvant Versus Adjuvant Therapy in Localized Pancreatic Cancer, after recently eclipsing breast cancer-related mortality and is expected to become the second leading cause of cancer-related mortality in the United States in the next decade, second only to lung cancer [1].作者: daredevil 時(shí)間: 2025-3-28 23:50 作者: BROTH 時(shí)間: 2025-3-29 03:19
Medical Nutrition Therapy Throughout the Continuum of Care for Localized Pancreatic Cancers,imary goals of dietary interventions are to prevent or reverse malnutrition, maintain scheduled course of treatments without delays, navigate symptom management improving quality of life, enhance recovery after surgery, and prevent or treat macro- and micronutrient deficiencies.作者: 不法行為 時(shí)間: 2025-3-29 08:44
Clinical Staging of Pancreatic Cancer with MDCT and MRI,rgery and discrimination of those who would not. High-quality cross-sectional imaging (MDCT and MRI) is vital in the detection, staging, and management of pancreatic cancer. This section will review the role of MDCT and MRI in the clinical staging of pancreatic cancer.作者: deactivate 時(shí)間: 2025-3-29 14:55 作者: Bouquet 時(shí)間: 2025-3-29 18:11
7樓作者: Parley 時(shí)間: 2025-3-29 22:54
7樓作者: Fracture 時(shí)間: 2025-3-30 03:32
7樓作者: 危險(xiǎn) 時(shí)間: 2025-3-30 07:58
7樓作者: 有幫助 時(shí)間: 2025-3-30 08:12
8樓作者: Orthodontics 時(shí)間: 2025-3-30 15:57
8樓作者: 蔑視 時(shí)間: 2025-3-30 18:38
8樓作者: inundate 時(shí)間: 2025-3-30 23:24
8樓作者: Mere僅僅 時(shí)間: 2025-3-31 03:58
9樓作者: 按等級(jí) 時(shí)間: 2025-3-31 09:00
9樓作者: gonioscopy 時(shí)間: 2025-3-31 10:26
9樓作者: FOVEA 時(shí)間: 2025-3-31 15:10
9樓作者: 公共汽車 時(shí)間: 2025-3-31 19:25
10樓作者: trigger 時(shí)間: 2025-3-31 23:41
10樓作者: Occupation 時(shí)間: 2025-4-1 02:20
10樓作者: 博識(shí) 時(shí)間: 2025-4-1 06:58
10樓
